The Liver Institute at Methodist Dallas

Dallas, Texas 75208

1 studies enrolling now · 15 studies all time

What they study most

Acute-On-Chronic Liver Failure, Ascites, Carcinoma, Hepatocellular, Chronic Hepatitis C, Compensated Liver Cirrhosis, HCV Infection, Hepatitis C, Hepatitis C, Chronic, Hepatoma, Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), NASH - Nonalcoholic Steatohepatitis

Studies at this site

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) — Recruiting now
• Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® — Stopped early
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects — Running, not enrolling
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — Running, not enrolling
• A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH — Completed
• A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease — Completed
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients — Completed
• SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma — Stopped early
• Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C — Completed
• Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C — Completed
• Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection — Completed
• Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV — Completed
• Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment — Completed
• A Study of MDX-1106 to Treat Patients With Hepatitis C Infection — Completed